Business Description
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | -0.35 | |||||
Debt-to-Equity | -1.35 | |||||
Debt-to-EBITDA | -0.2 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 54.9 | |||||
3-Year EPS without NRI Growth Rate | 22.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 1.12 | |||||
14-Day RSI | 9.06 | |||||
6-1 Month Momentum % | 43.71 | |||||
12-1 Month Momentum % | -50.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.74 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 8638.33 | |||||
Days Payable | 1727.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -624.19 | |||||
ROA % | -212.5 | |||||
ROIC % | -276.13 | |||||
ROC (Joel Greenblatt) % | -271.32 | |||||
ROCE % | -623.11 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -4.44 | |||||
EV-to-EBITDA | -4.44 | |||||
EV-to-FCF | -10.26 | |||||
Earnings Yield (Greenblatt) % | -22.52 | |||||
FCF Yield % | -10.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Neurone Studio SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | |||
EPS (TTM) (zł) | -0.272 | ||
Beta | 0.08 | ||
Volatility % | 123.64 | ||
14-Day RSI | 9.06 | ||
14-Day ATR (zł) | 0.009899 | ||
20-Day SMA (zł) | 1.188 | ||
12-1 Month Momentum % | -50.82 | ||
52-Week Range (zł) | 0.835 - 2.76 | ||
Shares Outstanding (Mil) | 2.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Neurone Studio SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Neurone Studio SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Neurone Studio SA Frequently Asked Questions
What is Neurone Studio SA(WAR:NRS)'s stock price today?
When is next earnings date of Neurone Studio SA(WAR:NRS)?
Does Neurone Studio SA(WAR:NRS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |